龚迪菲, 方莲花*, 杜冠华*. 线粒体自噬为靶点的抗缺血性心脏病天然药物研究进展J. 药学学报, 2021,56(7): 1872-1879. doi: 10.16438/j.0513-4870.2021-0184
引用本文: 龚迪菲, 方莲花*, 杜冠华*. 线粒体自噬为靶点的抗缺血性心脏病天然药物研究进展J. 药学学报, 2021,56(7): 1872-1879. doi: 10.16438/j.0513-4870.2021-0184
GONG Di-fei, FANG Lian-hua*, DU Guan-hua*. Research progress of natural drugs targeting mitochondrial autophagy against ischemic heart diseaseJ. Acta Pharmaceutica Sinica, 2021,56(7): 1872-1879. doi: 10.16438/j.0513-4870.2021-0184
Citation: GONG Di-fei, FANG Lian-hua*, DU Guan-hua*. Research progress of natural drugs targeting mitochondrial autophagy against ischemic heart diseaseJ. Acta Pharmaceutica Sinica, 2021,56(7): 1872-1879. doi: 10.16438/j.0513-4870.2021-0184

线粒体自噬为靶点的抗缺血性心脏病天然药物研究进展

Research progress of natural drugs targeting mitochondrial autophagy against ischemic heart disease

  • 摘要: 缺血性心脏病(ischemic heart disease,IHD)是威胁人类健康的主要原因,全球发病率和死亡率逐年升高,其主要病因是由于冠状动脉的狭窄或阻塞。线粒体功能异常是缺血性心脏病和再灌注损伤的主要病理基础,适度的线粒体自噬可以选择性清除受损蛋白质和细胞器维持细胞内环境稳定,对于心肌细胞的稳态非常重要。天然药物在缺血性心脏病中应用广泛、作用明显,近年来越来越多的研究表明有关天然药物可通过调控线粒体自噬水平,达到降低线粒体损伤、改善心肌缺血、减轻缺血性心脏病的目的。本文就近年来调节线粒体自噬的抗缺血性心脏病的天然药物进行综述。

     

    Abstract: Ischemic heart disease (IHD), which has been considered to be exclusively caused by stenosis or occlusion of coronary artery, is a significant cause of morbidity and mortality worldwide. Mitochondrial dysfunction is the main pathological basis of ischemic heart disease and reperfusion injury, and moderate mitochondrial autophagy can selectively remove damage proteins and organelles to maintain intracellular homeostasis, so mitochondrial autophagy is important for maintaining the homeostasis of cardiomyocytes. Natural drugs from plants are widely used in ischemic heart disease. In recent years, more and more natural drugs have been proven to alleviate myocardial cell damage after ischemia/reperfusion through mitochondrial autophagy. This paper reviews the research progress of natural drugs from plants medicines regulating mitochondrial autophagy in the treatment of ischemia heart disease.

     

/

返回文章
返回